Introduction and Aims: To determine the risk factors for new-onset diabetes after transplantation (NODAT) Methods: This is a retrospective observational cohort study. All adult patients transplanted over a 9 year period were included provided that they had no evidence of pre-transplant diabetes and had a functioning graft for ≥12 months. Data collected include age, sex, family history (FH) of diabetes, BMI and type of donor source. The pre-transplant fasting blood sugar (FBS) levels, at and during the first 24 hours post transplantation, at 6 months and 12 months post-transplant were measured. Results: There were 279 patients in the study with a mean age of 36.3±13.2 years, mean BMI of 26.5±7.2 and mean pre-transplant FBS of 5.0±0.8 mmol/l, which rose to 9.6± 4.8 mmol/l after 24 hours with the highest level during the first 24 hours being
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Methods: This is a retrospective observational cohort study. All adult patients transplanted over a 9 year period were included provided that they had no evidence of pre-transplant diabetes and had a functioning graft for ≥12 months. Data collected include age, sex, family history (FH) of diabetes, BMI and type of donor source. The pre-transplant fasting blood sugar (FBS) levels, at and during the first 24 hours post transplantation, at 6 months and 12 months post-transplant were measured. Results: There were 279 patients in the study with a mean age of 36.3±13.2 years, mean BMI of 26.5±7.2 and mean pre-transplant FBS of 5.0±0.8 mmol/l, which rose to 9.6± 4.8 mmol/l after 24 hours with the highest level during the first 24 hours being 14.1-±8.3 mmol/l. Fifty-seven patients (20.4%) developed NODAT. This group was significantly older (43.6±10.7 versus 34.2±13.1 years respectively; p=0.000), heavier (78.8±13.7 versus 66.9 ±19.2 kgs respectively; p=0.000), with higher BMI (30.6±5.0 versus 25.8±7.0 respectively; p=0.000) than the group that did not. They also had a higher FBS level after 24 hours of transplantation (10.9±4.1 versus 9.4±4.9 mmol/l respectively; p=0.03), at 6 months (7.9±3.7 versus 5.3±1.0 mmol/l respectively; p=0.000) and at 12 months (9.0±3.8 versus 5.3±1.0 mmol/l respectively; p=0.000) (table 2). No significant differences were observed between the two groups in height, FBS in the pre transplant workup or serum creatinine levels at 6 or 12 months. The incidence of NODAT was not affected by gender (13% in males and 18.5% in females ( p=0.2) or by kidney donor type (15.8% for LD and 15.0% for DD ( p=0.9). However, it was significantly higher in those with a FH of DM than to those without (37.2 % and 1.2 % respectively (P=0.000 (RR 31.3; In the group with NODAT, 18.0% had a FBS at 24 hours >6 (mmol/l) but only 4% with FBS at 24 hours 35 year but only 8.8 % were aged 26.1 but only 5.9 % had a BMI of < 26.1 ( p=0.000) (RR 1.26 95% CI 1.136 to 1.406) and 37.7 % had a FH of DM but only 1.2 % had no FH of DM ( p=0.000) (RR 31.3 95% CI 7.730 
